Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells
- PMID: 26094816
- PMCID: PMC4552512
- DOI: 10.1111/imm.12494
Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells
Abstract
Natural killer (NK) cells are considered critical components of the innate and adaptive immune responses. Deficiencies in NK cell activity are common, such as those that occur in cancer patients, and they can be responsible for dysfunctional immune surveillance. Persistent oxidative stress is intrinsic to many malignant tumours, and numerous studies have focused on the effects of reactive oxygen species on the anti-tumour activity of NK cells. Indeed, investigations in animal models have suggested that one of the most important thiol-dependent antioxidant enzymes, peroxiredoxin 1 (PRDX1), is essential for NK cell function. In this work, our analysis of the transcriptomic expression pattern of antioxidant enzymes in human NK cells has identified PRDX1 as the most prominently induced transcript out of the 18 transcripts evaluated in activated NK cells. The change in PRDX1 expression was followed by increased expression of two other enzymes from the PRDX-related antioxidant chain: thioredoxin and thioredoxin reductase. To study the role of thiol-dependent antioxidants in more detail, we applied a novel compound, adenanthin, to induce an abrupt dysfunction of the PRDX-related antioxidant chain in NK cells. In human primary NK cells, we observed profound alterations in spontaneous and antibody-dependent NK cell cytotoxicity against cancer cells, impaired degranulation, and a decreased expression of activation markers under these conditions. Collectively, our study pinpoints the unique role for the antioxidant activity of the PRDX-related enzymatic chain in human NK cell functions. Further understanding this phenomenon will prospectively lead to fine-tuning of the novel NK-targeted therapeutic approaches to human disease.
Keywords: degranulation; natural killer cells; oxidative stress; peroxiredoxin; tumour surveillance.
© 2015 John Wiley & Sons Ltd.
Figures





Similar articles
-
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.Br J Cancer. 2018 Oct;119(7):873-884. doi: 10.1038/s41416-018-0263-y. Epub 2018 Oct 5. Br J Cancer. 2018. PMID: 30287919 Free PMC article.
-
Interaction of adenanthin with glutathione and thiol enzymes: selectivity for thioredoxin reductase and inhibition of peroxiredoxin recycling.Free Radic Biol Med. 2014 Dec;77:331-9. doi: 10.1016/j.freeradbiomed.2014.09.025. Epub 2014 Oct 5. Free Radic Biol Med. 2014. PMID: 25289458
-
The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.Exp Hematol. 2006 Jun;34(6):753-9. doi: 10.1016/j.exphem.2006.02.015. Exp Hematol. 2006. PMID: 16728280
-
The thioredoxin antioxidant system.Free Radic Biol Med. 2014 Jan;66:75-87. doi: 10.1016/j.freeradbiomed.2013.07.036. Epub 2013 Jul 27. Free Radic Biol Med. 2014. PMID: 23899494 Review.
-
Peroxiredoxin 1 - an antioxidant enzyme in cancer.J Cell Mol Med. 2017 Jan;21(1):193-202. doi: 10.1111/jcmm.12955. Epub 2016 Sep 21. J Cell Mol Med. 2017. PMID: 27653015 Free PMC article. Review.
Cited by
-
Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells.Antioxidants (Basel). 2020 Apr 16;9(4):320. doi: 10.3390/antiox9040320. Antioxidants (Basel). 2020. PMID: 32316111 Free PMC article.
-
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.Cancer Immunol Immunother. 2017 May;66(5):605-613. doi: 10.1007/s00262-017-1969-z. Epub 2017 Feb 21. Cancer Immunol Immunother. 2017. PMID: 28224212 Free PMC article.
-
Peroxiredoxin, Senescence, and Cancer.Cells. 2022 May 28;11(11):1772. doi: 10.3390/cells11111772. Cells. 2022. PMID: 35681467 Free PMC article. Review.
-
Prospects for NK Cell Therapy of Sarcoma.Cancers (Basel). 2020 Dec 11;12(12):3719. doi: 10.3390/cancers12123719. Cancers (Basel). 2020. PMID: 33322371 Free PMC article. Review.
-
Scaffolding LSD1 Inhibitors Impair NK Cell Metabolism and Cytotoxic Function Through Depletion of Glutathione.Front Immunol. 2020 Sep 17;11:2196. doi: 10.3389/fimmu.2020.02196. eCollection 2020. Front Immunol. 2020. PMID: 33042135 Free PMC article.
References
-
- Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9:503–10. - PubMed
-
- Van Elssen CH, Oth T, Germeraad WT, Bos GM, Vanderlocht J. Natural killer cells: the secret weapon in dendritic cell vaccination strategies. Clin Cancer Res. 2014;20:1095–103. - PubMed
-
- Crome SQ, Lang PA, Lang KS, Ohashi PS. Natural killer cells regulate diverse T cell responses. Trends Immunol. 2013;34:342–9. - PubMed
-
- Kaszubowska L, Kaczor JJ, Hak L, Dettlaff-Pokora A, Szarynska M, Kmiec Z. Sensitivity of natural killer cells to activation in the process of ageing is related to the oxidative and inflammatory status of the elderly. J Physiol Pharmacol. 2011;62:101–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous